| Results summary | View all lists in L2L MDB | View all genes in D07A.profile.ud50 |
|
Down-regulated in fibroblasts following infection with human cytomegalovirus (at least 3-fold, with Affymetrix change call, in at least two consectutive timepoints) enrichment: 4.58-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 203973_S_AT | CEBPD | R | CCAAT/enhancer binding protein (C/EBP), delta | ||||||||||
| 217999_S_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 216250_S_AT | LPXN | P | C | S | leupaxin | ||||||||
| 213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
| 217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 201110_S_AT | THBS1 | D | X | C | thrombospondin 1 | ||||||||
| 203438_AT | STC2 | C | S | stanniocalcin 2 | |||||||||
| 209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 202437_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
| 202887_S_AT | DDIT4 | DNA-damage-inducible transcript 4 | |||||||||||
| 202435_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
| 209373_AT | MALL | mal, T-cell differentiation protein-like | |||||||||||
| 217996_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 201041_S_AT | DUSP1 | X | E | P | dual specificity phosphatase 1 | ||||||||
| 209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
| 202436_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||